Adelaide Medical School
Faculty of Health and Medical Sciences
Rong is a PhD student in pharmacogenetics and currently supervised by Professor Andrew Somogyi, Professor Betty Sallustio, Dr Janet Coller and Dr Daniel Barratt. She is now participating in a tacrolimus project in kidney transplant recipients and aiming to find genetic predictors for tacrolimus dose variability, acute rejection and kidney dysfunction.
Awards and Achievements
Date Type Title Institution Name Country Amount 2018 Award Adelaide Medical School Research Travel Awards Adelaide Medical School Australia $816 2018 Award The Hospital Research Foundation travel award The Hospital Research Foundation Australia $790 2017 Award 3MT (2017) Northern Communities Health Foundation Prize Faculty of Health & Medical Science & Northern Communities Health Foundation Australia $500 2017 Award Adelaide Medical School Research Travel Awards Adelaide Medical School Australia $1,000 2016 Award ASCEPT Pharmacogenomics Special Interest Group Prize, 2016 The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Australia — 2015 Scholarship Adelaide Scholarship International — — —
Language Competency Chinese (Cantonese) Can speak and understand spoken Chinese (Mandarin) Can read, write, speak and understand spoken English Can read, write, speak and understand spoken
Date Institution name Country Title 2015 University of Adelaide, Adelaide Australia PhD candidate
Year Citation 2019 Hu, R., Barratt, D., Coller, J., Sallustio, B., & Somogyi, A. (2019). Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation. Pharmacogenetics and Genomics, 29(1), 9-17.
2019 Hu, R., Barratt, D., Coller, J., Sallustio, B., & Somogyi, A. (2019). Is there a temporal relationship between trough whole blood tacrolimus concentration and acute rejection in the first 14 days after kidney transplantation?. Therapeutic Drug Monitoring, 41(4), 528-532.
2018 Hu, R., Barratt, D., Coller, J., Sallustio, B., & Somogyi, A. (2018). CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantation. Basic and Clinical Pharmacology and Toxicology, 123(3), 320-326.
DOI Scopus2 WoS3
2018 Xu, Z., Zhang, S., Huang, M., Hu, R., Li, J., Cen, H., . . . Zhang, X. (2018). Genotype-guided Warfarin Dosing in Patients with Mechanical Valves: a Randomized Controlled Trial. Annals of Thoracic Surgery, 106(6), 1774-1781.
2014 Cai, Y., Xu, C., Chen, P., Hu, J., Hu, R., Huang, M., & Bi, H. (2014). Development, validation, and application of a novel 7-day Caco-2 cell culture system. Journal of Pharmacological and Toxicological Methods, 70(2), 175-181.
DOI WoS11 Europe PMC4
Year Citation 2016 Hu, R. (2016). CYP3A5*3 and ABCB1 haplotype 61A-1199G-1236T-2677T/A-3435T are associated with dose-adjusted trough blood tacrolimus concentration in kidney transplant recipients. In ASCEPT-MPGPCR 2016. Melbourne, Australia.
Connect With Me